Coronavirus: PM says Canada has deal with Novavax to produce its COVID-19 vaccine in Canada ctvnews.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ctvnews.ca Daily Mail and Mail on Sunday newspapers.
Trudeau announces 2 companies are on track to produce COVID-19 vaccines in Canada
by Michael Ranger, News Staff
Posted Feb 2, 2021 4:00 am EDT
Last Updated Feb 2, 2021 at 3:50 pm EDT
Summary
Novavax s vaccine is likely at least two months away from being approved in Canada
Canada has a deal to buy 52 million doses from Novavax after it is approved by Health Canada
All doses from the approved vaccines being produced by Pfizer and Moderna are being made in Europe
Prime Minister Justin Trudeau has announced a deal with Novavax to produce doses of its new COVID-19 vaccine at a new National Research Council biomanufacturing facility in Montreal.
OTTAWA Prime Minister Justin Trudeau says a deal has been struck with Novavax to produce its COVID-19 vaccine in Canada, but the pharmaceutical company isn’t expected to be ready to roll out doses domestically until the fall at the earliest. The federal government has signed a “memorandum of understanding” with Novavax to pursue options to produce its COVID-19 vaccine at a new Montreal facility that is under construction. While the prime minister is calling this a “major step forward,” it could be months before this potential first made-in-Canada vaccine candidate is approved, let alone shipped to delivery sites nationwide.
Ottawa Signs Deal With Novavax to Produce COVID-19 Vaccine Domestically
Prime Minister Justin Trudeau announced Tuesday that the federal government has signed a memorandum of understanding with drug maker Novavax to produce COVID-19 vaccines domestically in Canada.
The vaccine production will take place at a new National Research Council’s Royalmount facility in Montreal, which is currently under construction and is expected to be finished by end of the year. Once it is completed, the facility will produce about two million doses of vaccines of all types every month.
Besides Novavax, Trudeau said the federal government has also invested $25 million into Precision Nanosystem, a drug manufacturer in Vancouver, to build a production facility capable of producing up to 240 million vaccine doses per year.
Article content
OTTAWA Prime Minister Justin Trudeau announced a tentative deal Tuesday with U.S. vaccine-maker Novavax to produce its product in Canada if the COVID-19 vaccine gets approved for use here.
“This is a major step forward to get vaccines made in Canada, for Canadians,” Trudeau said.
We apologize, but this video has failed to load.
Try refreshing your browser, or Canada signs deal with Novavax to make COVID-19 vaccine at new Montreal facility Back to video
But the agreement isn’t going to ease pressure on the government to get vaccines into Canada, because Novavax first has to get its vaccine approved, the National Research Council has to finish building a new facility in Montreal where the doses will be made, and that facility has to be certified to make the vaccines.